Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date LESSONS & BENEFITS GAINED FROM THE IMPLEMENTATION OF AN AUTOMATED BET SOLUTION Dennis Wong Global at AstraZeneca Liverpool UK and Jordi Iglesias at Charles River The webinar will provide an insight into a global deployment program for an automated solution for Endotoxin testing. A range of implementation aspect... March 9, 2023 3:00pm Points to consider when defining a microbial control strategy... Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy) Full title: Points to consider when defining a microbial control strategy for individualized ATMPs How are individualized ATMPs different from tradit... April 5, 2023 5:00pm Contamination Control Challenges Facing Cell Therapy Facilities Conor McMorrow at Takeda and Félix Montero-Julian at bioMérieux The presentation aims to provide an overview of challenges that can be faced with the knowledge that a one size fits all approach cannot be taken. Whi... April 17, 2023 2:00pm Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release... John Duguid at Vericel Corporation, Lori Daane at bioMerieux and Mike Brewer at Thermo Fisher Scientific Full Title: Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review 3 months ago | 132 mins Regulatory Strategies For Rapid Sterility Testing... Dr. Michael J. Miller, at Microbiology Consultants, LLC and Lori Daane, at bioMérieux Full Title: Regulatory Strategies For Rapid Sterility Testing of Gene and Cell Therapy Products The need to utilize rapid sterility testing is gainin... 11 months ago | 122 mins Annex 1 and Environmental Monitoring Program - Implementation And Justification. Benoit Ramond at Sanofi and Laurent Leblanc at bioMérieux Full Title: Annex 1 and Environmental Monitoring Program - Implementation And Justification of The Best Practices In Routine What is new? How to impl... 4 months ago | 118 mins We Are Going Back to the Future with Rapid Methods Dr. Michael J. Miller, at Microbiology Consultants, LLC and Félix Montero-Julian, Scientific Director at bioMérieux Rapid methods have been available to the pharmaceutical industry for decades. And although global regulations have changed to encourage their use, esp... 12 months ago | 111 mins Rapid methods- The Next Phase : A Framework For Multi-Product Adoption... Miriam Guest, at AstraZeneca UK and Ulrich Herber at Charles River Full Title: Rapid methods- The Next Phase : A Framework For Multi-Product Adoption Of Rapid Sterility Testing The adoption of rapid sterility testing... 1 year ago | 120 mins Just in Time Release of CAR T Cell Therapies During Covid-19 Irving Ford at Bristol Myers Squibb and Lori Daane at bioMérieux Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb 10 months ago | 78 mins Reducing Microbiological Risk & Using Quality Tools in the Pharma Industry Don Singer, GlaxoSmithKline R&D and Jessica Rayser, Product Manager at Charles River The pharmaceutical industry paradigm change is occurring and industry has taken an important leap towards formality of quality improvement using quali... 4 years ago | 55 mins Load more
